The Oxford-based biotech company has secured £13.2m to progress world’s vital treatment development More: SynaptixBio receives incurable disease research boost Source: News
read moreProduct delivers epigenetic information from a single low-input DNA library without medical treatment More: Biomodal releases genetics and epigenetics solution Source: News
read moreSickle cell disease gene therapies from Vertex, bluebird can be cost-effective at $1.9M: ICER aliu Thu, 04/13/2023 – 11:08 More: Sickle cell disease gene therapies from Vertex, bluebird can be cost-effective at .9M: ICER Source: fierce
read morePharma passes tech to climb to 2nd place on ad spend leaderboard amid boom in digital promotions ntaylor Thu, 04/13/2023 – 10:26 More: Pharma passes tech to climb to 2nd place on ad spend leaderboard amid boom in digital promotions
read moreUCB loses its appeal in Neupro patent case, giving Teva and Viatris a win zbecker Thu, 04/13/2023 – 10:05 More: UCB loses its appeal in Neupro patent case, giving Teva and Viatris a win Source: fierce
read moreGSK throws counterpunch as ‘skinny’ label feud with Teva circles Supreme Court fkansteiner Thu, 04/13/2023 – 10:05 More: GSK throws counterpunch as 'skinny' label feud with Teva circles Supreme Court Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals